Mobocertinib
| CAS No. | 1847461-43-1 | Cat. No. | BCP31045 |
| Name | Mobocertinib | ||
| Synonyms | TAK-788;TAK 788; TAK788; AP32788; AP-32788; AP 32788; | ||
| Formula | C32H39N7O4 | M. Wt | 585.71 |
| Description | Mobocertinib, also known as TAK-788 and AP32788, is an investigational TKI with potent, selective preclinical activity against activating EGFR and HER2 mutations, including exon 20 insertions. TAK-788 exhibits antitumor activity in pts with EGFR exon 20 insertions with an AE profile consistent with other EGFR TKIs. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway | ||
| Targets | EGFR HER2 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.